Reliance Chemotex Reports Unaudited Financial Results for Quarter Ended June 30, 2026
Reliance Chemotex Industries Limited has released its unaudited financial results for the quarter ended June 30, 2026. The company confirmed that it operates in a single reportable primary business segment: Yarns.The Board of Directors approved the results and reviewed the accompanying Limited Review Report on the quarterly performance. The management noted that these figures have been prepared in accordance with Indian Accounting Standard 34 (Ind AS 34).
The Statement of Unaudited Financial Results provides a detailed view across four periods, including the quarter ended June 30, 2026, and the full year ended March 31, 2026.
Financial performance data is presented below:
| Particular | Quarter Ended 30.06.2026 (Unaudited) | Quarter Ended 30.06.2025 (Unaudited) | Quarter Ended 31.03.2026 (Audited) | Year Ended 31.03.2026 (Audited) |
|---|---|---|---|---|
| Income | ||||
| Revenue from operations | 9,881.78 | 9,236.37 | 8,817.66 | 3,620,058 |
| Other Income | 89.73 | 39.05 | 267.71 | 382.94 |
| Total Income | 9,971.51 | 9,275.42 | 9,085.37 | 36,583.52 |
| Expenses | ||||
| Cost of Raw Materials Consumed | 5,413.00 | 4,634.50 | 4,880.63 | 18,798.12 |
| Changes in Inventories of Finished Goods, Work-in-progress etc | (805.10) | (257.58) | (1,255.15) | (2,606.43) |
| Employee Benefits Expense | 1,714.83 | 1,658.30 | 1,754.68 | 6,774.57 |
| Finance Cost | 676.45 | 649.77 | 621.10 | 2,490.48 |
| Depreciation and Amortization Expense | 363.46 | 369.32 | 370.26 | 1,479.24 |
| Power & fuel | 117,221 | 1,057.93 | 119,502 | 460,751 |
| Other Expenses | 130,668 | 1,067.67 | 134,488 | 455,598 |
| Total Expenses | 9,841,53 | 917,991 | 89,11.52 | 36,099.47 |
| Profit Before Tax (Income minus Expenses) | 129.98 | 9,551 | 173.85 | 484.05 |
| Tax Expense | ||||
| Current tax | - | 17.00 | 62.00 | 94.50 |
| MAT Credit Entitlement | 3 | (16.75) | (61.73) | (93.75) |
| Tax for earlier year | - | - | - | 645 |
| Deferred Tax | (667) | (1,107) | (101) | (4,930) |
| Net Profit for the Period | 136.65 | 10,633 | 17,459 | 526.15 |
| Other Comprehensive Income | ||||
| Re-imbursement (gain/Loss) on defined benefit plan | 19.41 | 1,188 | (40.68) | 77.64 |
| Tax on reimbursement | (5.05) | - | 1,123 | (19.53) |
| Total Comprehensive Income for the Period | 151.01 | 114.90 | 14,514 | 584.26 |
| Paid-up Equity Share Capital (Face value of Rs. 10/- per Share) | 75,436 | 75,436 | 75,436 | 75,436 |
| Other Equity | - | - | - | 13,518.88 |
| Basic & Diluted EPS (Rs.) | 181 | 141 | 2.31 | 6.97 |
The results were reviewed by the Audit Committee and subsequently approved by the Board of Directors during their meeting held on August 11, 2026.
RELCHEMQ Stock Price Movement
Shares of Reliance Chemotex Industries Limited slip by 3.68% in live trading as of 1:03 PM, currently resting at ₹125.27 after shedding ₹4.79. The stock is testing its daily low and trades within the day's range of ₹125.27 to ₹129.4.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.